Session Coverage

An expert panel said that the most effective care frequently lies not in rigid adherence to algorithms but in the thoughtful application of clinical expertise to the shades of gray that define real-world practice.

Although crowd control weapons and chemical agents are often described as “less lethal,” they can produce serious trauma, toxic exposures, and respiratory complications in patients.

Panelists emphasized that health care is a team effort, not only when it comes to supporting patients but also when helping fellow clinicians navigate challenges.

Clearing a patient for surgery isn’t a simple yes-or-no decision but a collaborative process of assessing and mitigating risk that involves pulmonary, cardiac, and anesthesiology teams, said Bilal Zafar, MD.

AI in pulmonary hypertension research and care requires rigorous validation, thoughtful implementation, and ongoing physician oversight, presenters said.

Speakers challenged attendees to rethink whether the visible metrics that dominate modern health care actually reflect meaningful accomplishment.

In recent years, important progress has been made in defining interstitial lung abnormalities (ILAs) and clarifying how to move from an ILA diagnosis to interstitial lung disease (ILD), explained Said Chaaban, MD, MBA, FCCP.

Diagnosing lung nodules can be a complex process, especially when granulomatous, inflammatory, and infectious nodules masquerade as malignancies, said Francisco Marquez, MD.

Acquired tracheoesophageal fistulas can be complicated by delayed diagnosis, malnutrition, infection, airway compromise, and underlying cancer, said Yaron B. Gesthalter, MD.

Presenters highlighted the importance of following the physiology as the clearest path to the correct diagnosis and treatment of complex cardiovascular cases.